[1]
2024. Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index. Biomolecules and Biomedicine. 25, 1 (Dec. 2024), 240–248. DOI:https://doi.org/10.17305/bb.2024.11155.